Assist. Prof. Dr. Arslan Sehgal | Bioinformatics | Best Researcher Award

Assist. Prof. Dr. Arslan Sehgal , Bioinformatics , Assistant Professor at Cholistan University of Veterinary and Animal Sciences, Pakistan

Dr. Arslan Sehgal is a passionate Pakistani scientist specializing in Bioinformatics and Computational Drug Design. Currently serving as an Assistant Professor at the Department of Genomics and Bioinformatics, Cholistan University of Veterinary and Animal Sciences, he is known for his extensive research in auto(mito)phagy, neurological disorders, and vaccine development. He completed his Ph.D. in Cell Biology (Bioinformatics) from the University of Chinese Academy of Sciences, Beijing, focusing on drug screening to inhibit mitophagy-related pathways. With more than 60 publications and an impressive h-index of 23, Dr. Sehgal is a leading voice in computational biology, particularly in the discovery of bioactive molecules through virtual screening, immunoinformatics, and structure-based drug design. His work on diseases like COVID-19, HCV, and cancer has received global recognition. Dr. Sehgal also actively mentors BS and MS students and is committed to integrating modern computational tools in biological research for therapeutic advancements.

Professional Profile :

Google Scholar

Summary of Suitability for Award:

Dr. Arslan Sehgal, an Assistant Professor in the Department of Genomics and Bioinformatics at Cholistan University of Veterinary and Animal Sciences, stands out as an exemplary candidate for the “Best Researcher Award.” His prolific research contributions encompass Bioinformatics, Computational Drug Design, and Immunoinformatics, with strong integration of chemical and biological sciences. With over 50 peer-reviewed publications, an H-index of 23, and 1677 citations, Dr. Sehgal has demonstrated sustained scientific excellence. He has published extensively as a first and corresponding author, highlighting his leadership in research. His expertise spans cancer biology, mitochondrial disorders, vaccine design, and antiviral drug discovery, underlining the translational potential of his work. Dr. Arslan Sehgal’s impressive academic track record, interdisciplinary research in computational biology and chemistry, and commitment to innovative drug discovery approaches make him highly suitable for the “Best Researcher Award.” His contributions have significantly advanced the fields of bioinformatics and computational pharmacology, earning him national and international recognition. He is a deserving and competitive nominee for this prestigious honour.

🎓Education:

Dr. Arslan Sehgal holds a Ph.D. in Cell Biology (Bioinformatics) from the University of Chinese Academy of Sciences, Beijing, China (2015–2019). His dissertation explored the screening of novel compounds targeting LC3 and FUNDC1 interaction for inhibition of auto(mito)phagy under the guidance of Prof. Dr. Quan Chen and Prof. Dr. Tieshan Tang. Prior to this, he completed his MS in Bioinformatics (2011–2013) at the International Islamic University Islamabad, where his research focused on genetic analysis related to schizophrenia. He began his academic journey with a BS in Bioinformatics (2006–2010) from Government College University Faisalabad, conducting a project on molecular characterization of wheat genotypes and database development using bioinformatics tools. Dr. Sehgal’s educational path reflects a consistent focus on blending molecular biology with computational methods, preparing him to solve complex biological problems using informatics and modeling techniques that contribute significantly to biomedical sciences.

🏢Work Experience:

Dr. Sehgal has held several academic positions. Currently, he is an Assistant Professor at Cholistan University of Veterinary and Animal Sciences (April 2024–Present), teaching and supervising research in genomics and computational medicine. Previously, he served as a Lecturer and then Assistant Professor (2022–2024) at The Islamia University of Bahawalpur, and from 2020–2022, he worked at the University of Okara as Assistant Professor (IPFP and Visiting). He also taught at Government College University Faisalabad (2019–2020) and COMSATS University Islamabad, Sahiwal Campus (2015). In all roles, Dr. Sehgal integrated computational biology with wet-lab research, mentored numerous BS/MS students, and initiated significant projects in drug design and immunoinformatics. His diverse roles involved curriculum development, lab management, and admission coordination. His academic journey reflects a strong commitment to bioinformatics education and research in Pakistani universities, with contributions that span across structural biology, molecular docking, and computational vaccinology.

🏅Awards:

Dr. Arslan Sehgal is widely recognized for his exceptional research output and scholarly excellence in computational biology and drug design. With a cumulative impact factor exceeding 200 and citations reaching 1677, he has garnered significant acclaim in the scientific community. His h-index of 23 and i10-index of 35 are testaments to his consistent and impactful research. He has published more than 60 peer-reviewed articles, including 31 as corresponding author, which underscores his leadership in scientific inquiry. His research contributions have been recognized both nationally and internationally, particularly in the fields of mitophagy, neuropharmacology, and epitope-based vaccine design. His work on SARS-CoV-2 and cancer-related pathways has drawn widespread attention for its originality and clinical relevance. While formal accolades are not listed, his publishing record and global collaboration reflect a high level of academic esteem and place him among the top-tier emerging scientists in computational bioinformatics from Pakistan.

🔬Research Focus:

Dr. Sehgal’s research centers on the integration of bioinformatics, structural biology, and computational drug design to explore therapeutic avenues against diseases like cancer, neurological disorders, and viral infections. He specializes in auto(mito)phagy, investigating molecular mechanisms and identifying inhibitors that can modulate mitochondrial turnover for therapeutic benefit. His work extensively employs structure-based drug design, molecular docking, molecular dynamics simulations, immunoinformatics, and subtractive genomics to screen and validate potential bioactive compounds and vaccine candidates. He has also pioneered efforts in reverse vaccinology for the development of epitope-based vaccines against SARS-CoV-2 and dengue virus. His recent research explores mitochondrial biogenesis, network pharmacology, and natural product-based therapeutic interventions. With an interdisciplinary approach, Dr. Sehgal’s work not only deciphers complex biological interactions but also translates them into practical pharmaceutical insights, contributing significantly to precision medicine and in-silico pharmacology. His goal is to reduce experimental overhead through reliable computational predictions.

Publication Top Notes:

“Recent Trends in Computer-Aided Drug Design for Anti-Cancer Drug Discovery”

“In Silico Designing of Multiepitope-Based-Peptide (MBP) Vaccine Against MAPK Protein Express for Alzheimer’s Disease in Zebrafish”

“Bioinformatics Approaches in Upgrading Microalgal Oil for Advanced Biofuel Production Through Hybrid ORF Protein Construction”

“Elucidation of Novel Compounds and Epitope-Based Peptide Vaccine Design Against C30 Endopeptidase Regions of SARS-CoV-2 Using Immunoinformatics Approaches”

“Comprehensive In Silico Analyses of Flavonoids Elucidating the Drug Properties Against Kidney Disease by Targeting AIM2”

“Pharmacological Progress of Mitophagy Regulation”

Citations: 5

“In Silico Elucidation of Potential Drug Targets Against Oxygenase Domain of Human eNOS Dysfunction”

“Synthesis and Characterization of Copper Oxide Nanoparticles: Its Influence on Corn (Z. mays) and Wheat (Triticum aestivum) Plants by Inoculation of Bacillus subtilis”

Citations: 20

“The Future of Health Diagnosis and Treatment: An Exploration of Deep Learning Frameworks and Innovative Applications”

Citations: 1

“The Multifaceted Regulation of Mitophagy by Endogenous Metabolites”

Citations: 112

Assoc Prof Dr. Nagaprasad Puvvada | Nanomedicine | Best Researcher Award

Associate Professor at VIT-AP University, India

Dr. Naga Prasad Puvvada is an accomplished researcher in the field of chemistry, specializing in nanotechnology and biomedical applications. He holds a Ph.D. from the Indian Institute of Technology, Kharagpur, and is currently an Associate Professor at VIT-AP University, Andhra Pradesh. His research focuses on the synthesis of nanomaterials for drug delivery, cancer therapeutics, and bioimaging, contributing significantly to advancements in biomedical sciences.

Author Metrics

ORCID Profile

Scopus Profile

Dr. Naga Prasad Puvvada has a significant academic footprint with a diverse range of publications. His works have been cited numerous times, contributing to an impressive H-index of 18 according to Web of Science. This reflects the impact and influence of his research in the field of chemistry, particularly in nanotechnology and biomedical applications.

Education

Dr. Puvvada earned his Ph.D. in Chemistry from the Indian Institute of Technology, Kharagpur in 2014. Prior to this, he completed his M.Sc. in Chemistry at the National Institute of Technology, Warangal, and his B.Sc. in Mathematics, Physics, and Chemistry from Hindu College, ANU University, Andhra Pradesh.

Research Focus

His research primarily focuses on nanotechnology and its applications in biomedical sciences. Dr. Puvvada specializes in the synthesis and characterization of nanomaterials for drug delivery, cancer therapeutics, and bioimaging. He is also involved in exploring the use of nanomaterials for neuroprotection and other biomedical applications.

Professional Journey

Dr. Puvvada’s professional journey includes diverse roles in academia and research. He is currently serving as an Associate Professor at VIT-AP University, Andhra Pradesh, where he continues to lead research initiatives in nanotechnology and chemistry. Previously, he held positions as an Assistant Professor at Indrashil University and as a DST Inspire Faculty at the Indian Institute of Chemical Technology, Hyderabad. He has also conducted postdoctoral research at Dalhousie Medicine New Brunswick, Canada.

Honors & Awards

Throughout his career, Dr. Puvvada has received several honors and awards for his contributions to science and research. These include the DST Inspire Faculty Award from the Government of India, the Telangana Academy Sciences-Young Scientist Award, and recognition for Best Oral Presentation by ACS Omega.

Publications Noted & Contributions

Dr. Puvvada has authored numerous publications in reputed journals, making significant contributions to the fields of nanotechnology, biochemistry, and materials science. His research spans topics such as the development of nanoparticles for targeted drug delivery, bioimaging using carbon dots, and nanocomposite materials for biomedical applications.

Title: Biocompatible fluorescent carbon nanoparticles as nanocarriers for targeted delivery of tamoxifen for regression of Breast carcinoma

Journal: Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
Publication Date: November 2024
DOI: 10.1016/j.saa.2024.124721
Contributors: Nagaprasad Puvvada; Md. Abdus Salam Shaik; Dipanjan Samanta; Manisha Shaw; Imran Mondal; Rajarshi Basu; Angana Bhattacharya; Amita Pathak

Title: Integrin receptor-targeted, doxorubicin-loaded cerium oxide nanoparticles delivery to combat glioblastoma

Journal: Nanomedicine
Publication Date: June 24, 2024
DOI: 10.1080/17435889.2024.2350357
Contributors: Gayathri Koula; Venu Yakati; Hari Krishnareddy Rachamalla; Keerti Bhamidipati; Muralidharan Kathirvel; Rajkumar Banerjee; Nagaprasad Puvvada

Title: Potential Benefits, Challenges and Perspectives of Various Methods and Materials Used for Hydrogen Storage

Journal: Energy & Fuels
Publication Date: February 15, 2024
DOI: 10.1021/acs.energyfuels.3c04084
Contributors: Pravas Kumar Panigrahi; Basavaiah Chandu; Mallikarjuna Rao Motapothula; Nagaprasad Puvvada

Title: Recent Advances in Nanostructured Materials for Application as Gas Sensors

Journal: ACS Omega
Publication Date: January 10, 2024
DOI: 10.1021/acsomega.3c06533
Contributors: Pravas Kumar Panigrahi; Basavaiah Chandu; Nagaprasad Puvvada

Title: Recent Advances in Chemically Engineered Nanostructures Impact on Ischemic Stroke Treatment

Journal: ACS Omega
Publication Date: December 5, 2023
DOI: 10.1021/acsomega.3c06228
Contributors: Gudivaka Sri Kanaka Durga Vijayalakshmi; Nagaprasad Puvvada

Research Timeline

His research timeline includes leading various projects focused on nanotechnology and biomedical applications. These projects have explored the use of nanoparticles for cancer therapy, neuroprotection, and biomedical diagnostics. Dr. Puvvada’s work also includes the development of novel nanomaterials and their applications in enhancing healthcare and medical treatments.

Collaborations and Projects

Dr. Puvvada has been actively involved in collaborative research initiatives both nationally and internationally. His collaborations have facilitated innovative research projects in nanotechnology and biomedical sciences, aiming to address critical healthcare challenges through advanced materials and technologies.

This summary provides a comprehensive overview of Dr. Naga Prasad Puvvada’s academic journey, research focus, and contributions to the field of chemistry and nanotechnology.